Literature DB >> 21431875

HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat.

Anding Liu1, Olaf Dirsch, Haoshu Fang, Jian Sun, Hao Jin, Wei Dong, Uta Dahmen.   

Abstract

High mobility group box 1 (HMGB1) acts as an early mediator in inflammation and organ injury. Ischemia reperfusion (I/R) injury induces HMGB1 translocation and expression in ischemic areas. However, it is unknown whether selective warm liver I/R injury also induces the expression of HMGB1 in non-ischemic lobes. The present study aimed to test the hypothesis that selective liver I/R injury also causes HMGB1 translocation and up-regulates its expression in non-ischemic liver areas. In the present study, selective I/R injury was induced by clamping the median and left lateral liver lobes for 90 min followed by 0.5, 6 and 24 h reperfusion. We used male inbred Lewis rats; six animals for each point in time and six animals for the normal control group. Selective hepatic I/R injury induced morphological changes not only in ischemic lobes but also in non-ischemic lobes. HMGB1 translocation and expression was increased in a time-dependent manner in the ischemic lobes, and increased in with delayed onset in the non-ischemic lobes. Serum HMGB1 levels were increased after reperfusion. Furthermore, liver I/R injury up-regulated the expression of HMGB1 receptors (Toll-like receptor 4 and receptor for advanced glycation end products and pro-inflammatory cytokines (Tumor necrosis factor-alpha and interleukin-6) in both ischemic lobes, however, the up-regulation of these cytokines was more prominent in the ischemic lobes. In conclusion, selective warm I/R induces a substantial "sympathetic/bystander" effect on the non-ischemic lobes in terms of HMGB1 translocation and local cytokine production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431875     DOI: 10.1007/s00418-011-0802-6

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  50 in total

Review 1.  New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

Authors:  S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

Review 2.  Mechanism of hepatocyte death after ischemia: apoptosis versus necrosis.

Authors:  P A Clavien; H A Rüdiger; M Selzner
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

3.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

4.  The extracellular release of HMGB1 during apoptotic cell death.

Authors:  Charles W Bell; Weiwen Jiang; Charles F Reich; David S Pisetsky
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-19       Impact factor: 4.249

5.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Authors:  L M Colletti; D G Remick; G D Burtch; S L Kunkel; R M Strieter; D A Campbell
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 6.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.

Authors:  Hartmut Jaeschke; John J Lemasters
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

7.  HMGB1 is an endogenous immune adjuvant released by necrotic cells.

Authors:  Patrizia Rovere-Querini; Annalisa Capobianco; Paola Scaffidi; Barbara Valentinis; Federica Catalanotti; Marta Giazzon; Ingrid E Dumitriu; Susanne Müller; Matteo Iannacone; Catia Traversari; Marco E Bianchi; Angelo A Manfredi
Journal:  EMBO Rep       Date:  2004-07-23       Impact factor: 8.807

Review 8.  Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection.

Authors:  Narci C Teoh; Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 4.029

Review 9.  High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.

Authors:  Marco E Bianchi; Angelo A Manfredi
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

10.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  18 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

2.  7,8-dihydroxycoumarin has a dual mechanism of action in hepatic ischemia reperfusion injury.

Authors:  Hai-Yang Zhu; Hong-Wei Gao; Shu-Feng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Impact of intestinal ischemia/reperfusion and lymph drainage on distant organs in rats.

Authors:  Gui-Zhen He; Kai-Guo Zhou; Rui Zhang; Yu-Kang Wang; Xue-Feng Chen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

4.  Inhibition of γ-glutamyltransferase ameliorates ischaemia-reoxygenation tissue damage in rats with hepatic steatosis.

Authors:  Ryuichi Kubota; Nobuhiko Hayashi; Kaori Kinoshita; Takashi Saito; Kazuaki Ozaki; Yoshimichi Ueda; Mutsumi Tsuchishima; Mikihiro Tsutsumi; Joseph George
Journal:  Br J Pharmacol       Date:  2020-10-19       Impact factor: 8.739

5.  G-CSF pretreatment aggravates LPS-associated microcirculatory dysfunction and acute liver injury after partial hepatectomy in rats.

Authors:  Anding Liu; Haoshu Fang; Weiwei Wei; Chunyi Kan; Chichi Xie; Uta Dahmen; Olaf Dirsch
Journal:  Histochem Cell Biol       Date:  2014-07-25       Impact factor: 4.304

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

7.  Pretreatment of cisplatin in recipients attenuates post-transplantation pancreatitis in murine model.

Authors:  Sheng Yan; Yuan Ding; Fei Sun; Zhongjie Lu; Liang Xue; Xiangyan Liu; Mingqi Shuai; Chen Fang; Yan Wang; Hui Cheng; Lin Zhou; Ming H Zheng; Shusen Zheng
Journal:  Int J Biol Sci       Date:  2012-02-01       Impact factor: 6.580

8.  Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion.

Authors:  Anding Liu; Haoshu Fang; Olaf Dirsch; Hao Jin; Uta Dahmen
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase.

Authors:  H Fang; A Liu; U Dahmen; O Dirsch
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

10.  Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β.

Authors:  Hyo Jeong Kim; Yeonsoo Joe; Jin Sun Kong; Sun-Oh Jeong; Gyeong Jae Cho; Stefan W Ryter; Hun Taeg Chung
Journal:  Oxid Med Cell Longev       Date:  2013-12-18       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.